Although many molecular biomarker candidates of ESCC, such as squamous cell carcinoma antigen (SCC-Ag), carcinoembryonic antigen (CEA), CA19–9, and mutated p53, have been identified; biomarkers with the necessary sensitivity and specificity are still lacking [9]. The gene discussed is CEACAM5; the disease is esophageal squamous cell carcinoma.